Prevention of Suicidal Behavior Through the VIGILANS Protocol: the Restoration of Social Connection Hypothesis

Recruiting N/A Interventional Study
Suicidal Behaviour Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 55
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
120 (estimated)
Sponsor
University Hospital, Montpellier · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The World Health Organization (WHO) estimates, with 800,000 annual deaths, that suicide is the second leading cause of death in people aged 10 to 44 and thus recognizes suicide prevention as a public health priority. The psychological impact of the COVID-19 pandemic, the social isolation and the economic consequences engendered by the confinement, as well as the direct effects of this viral infect…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
For all subjects: * Patients benefiting from VigilanS monitoring at CHU Montpellier / Nîmes * aged between 18 and 55 years old; * able to understand experimental procedures * able to speak, read and understand French * able to give written informed consent Specific inclusion criteria: TS+: Had an…
Contacts

Philippe Courtet, PhD

p-courtet@chu-montpellier.fr

CONTACT

Maude SENEQUE

m-senequehaize@chu-montpellier.fr

CONTACT